{"id":19211,"date":"2024-10-21T09:32:33","date_gmt":"2024-10-21T08:32:33","guid":{"rendered":"https:\/\/actubusinessangels.com\/?p=19211"},"modified":"2024-10-21T09:32:33","modified_gmt":"2024-10-21T08:32:33","slug":"genexpath-est-membre-du-programme-paris-saclay-cancer-cluster","status":"publish","type":"post","link":"https:\/\/www.franceangels.org\/en\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/","title":{"rendered":"Genexpath est membre du programme Paris Saclay Cancer Cluster"},"content":{"rendered":"\n<p class=\"has-text-align-justify\"><strong><a href=\"https:\/\/www.genexpath.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Genexpath<\/a><\/strong>, soutenue par <strong><a href=\"https:\/\/www.angelssante.fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">Angels Sant\u00e9<\/a><\/strong>, fait d\u00e9sormais partie aupr\u00e8s de 6 autres start-ups du programme <strong><a href=\"https:\/\/www.parissaclaycancercluster.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">Paris Saclay Cancer Cluster<\/a><\/strong>.<\/p>\n\n\n\n<!--more-->\n\n\n\n<p><strong>Genexpath, qui sont-ils ?<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-justify\">Bas\u00e9e \u00e0 Rouen, la start-up d\u00e9veloppe et produit des kits de diagnostic des cancers. Bas\u00e9s sur des technologies innovantes et brevet\u00e9es, ces produits permettent d\u2019\u00e9tablir des diagnostics fiables et rapides, sans achat de mat\u00e9riel suppl\u00e9mentaire. <\/p>\n\n\n\n<p class=\"has-text-align-justify\">Genexpath est n\u00e9e de la volont\u00e9 de mettre \u00e0 disposition du plus grand nombre les travaux de recherche ayant montr\u00e9 leur efficacit\u00e9 dans la caract\u00e9risation de plusieurs cancers dont les sarcomes et les lymphomes. La prise en charge du patient en est ainsi am\u00e9lior\u00e9e.<\/p>\n\n\n\n<p><strong>Quel est l&#8217;ambition de Paris Saclay Cancer Cluster ?<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-justify\">Premier laur\u00e9at du programme France 2030 NextGenerationEU, le Paris Saclay Cancer Cluster (PSCC) change le rythme de l&#8217;innovation en canc\u00e9rologie pour la rendre plus pr\u00e9dictive, pr\u00e9cise et efficace. Pour acc\u00e9l\u00e9rer cette transformation, l&#8217;oncocluster fran\u00e7ais offre l&#8217;acc\u00e8s aux meilleures expertises, outils et services aux chercheurs et d\u00e9veloppeurs europ\u00e9ens prometteurs, notamment des mentors, des r\u00e9seaux, des financements, des donn\u00e9es, des \u00e9chantillons, des technologies, des infrastructures et des laboratoires.<\/p>\n\n\n\n<p class=\"has-text-align-justify\">Cet \u00e9cosyst\u00e8me unique, ax\u00e9 sur le patient, au c\u0153ur du Grand Paris, \u00e0 proximit\u00e9 des grands centres de recherche, cliniques et d&#8217;innovation fran\u00e7ais, est le plus grand d&#8217;Europe, avec pr\u00e8s de 80 membres et 9 nationalit\u00e9s. Cr\u00e9\u00e9 en f\u00e9vrier 2022 \u00e0 l&#8217;initiative de l&#8217;Universit\u00e9 Paris-Saclay, de l&#8217;Institut Polytechnique de Paris, de l&#8217;Inserm, de l&#8217;Institut Gustave Roussy et de Sanofi, le PSCC est un continuum d&#8217;excellence, r\u00e9unissant organismes de recherche, universit\u00e9s, h\u00f4pitaux, start-ups, scale-ups, industriels, capital-investisseurs, associations de patients, gouvernement, collectivit\u00e9s locales et parties prenantes.<\/p>\n\n\n\n<p class=\"has-text-align-justify\"><strong>Cette s\u00e9lection au sein de Paris Saclay Cancer Cluster va permettre \u00e0 Genexpath de poursuivre son d\u00e9veloppement, d&#8217;acc\u00e9der \u00e0 de nombreuses expertises, outils et services propos\u00e9s par le PSCC.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Genexpath, soutenue par Angels Sant\u00e9, fait d\u00e9sormais partie aupr\u00e8s de 6 autres start-ups du programme Paris Saclay Cancer Cluster.<\/p>\n","protected":false},"author":114,"featured_media":19218,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false},"categories":[158,87],"tags":[147,1260,1311,1312,1313,163],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.7.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Genexpath est membre du programme Paris Saclay Cancer Cluster - France Angels<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genexpath est membre du programme Paris Saclay Cancer Cluster - France Angels\" \/>\n<meta property=\"og:description\" content=\"Genexpath, soutenue par Angels Sant\u00e9, fait d\u00e9sormais partie aupr\u00e8s de 6 autres start-ups du programme Paris Saclay Cancer Cluster.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/\" \/>\n<meta property=\"og:site_name\" content=\"France Angels\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/france.angels\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-21T08:32:33+00:00\" \/>\n<meta name=\"author\" content=\"France Angels\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@franceangels\" \/>\n<meta name=\"twitter:site\" content=\"@franceangels\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"France Angels\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/\"},\"author\":{\"name\":\"France Angels\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\"},\"headline\":\"Genexpath est membre du programme Paris Saclay Cancer Cluster\",\"datePublished\":\"2024-10-21T08:32:33+00:00\",\"dateModified\":\"2024-10-21T08:32:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/\"},\"wordCount\":325,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"keywords\":[\"Angels Sant\u00e9\",\"France 2030\",\"France 2030 NextGenerationEU\",\"Genexpath\",\"Paris Saclay Cancer Cluster\",\"Programme\"],\"articleSection\":[\"L'\u00e9cosyst\u00e8me\",\"La start-up du mois\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/\",\"url\":\"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/\",\"name\":\"Genexpath est membre du programme Paris Saclay Cancer Cluster - France Angels\",\"isPartOf\":{\"@id\":\"https:\/\/www.franceangels.org\/#website\"},\"datePublished\":\"2024-10-21T08:32:33+00:00\",\"dateModified\":\"2024-10-21T08:32:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.franceangels.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Genexpath est membre du programme Paris Saclay Cancer Cluster\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.franceangels.org\/#website\",\"url\":\"https:\/\/www.franceangels.org\/\",\"name\":\"France Angels\",\"description\":\"F\u00e9d\u00e9ration Nationale des Business Angels\",\"publisher\":{\"@id\":\"https:\/\/www.franceangels.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.franceangels.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.franceangels.org\/#organization\",\"name\":\"France Angels\",\"url\":\"https:\/\/www.franceangels.org\/\",\"sameAs\":[\"https:\/\/linkedin.com\/company\/france-angels\",\"https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q\",\"https:\/\/facebook.com\/france.angels\/\",\"https:\/\/twitter.com\/franceangels\"],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"contentUrl\":\"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png\",\"width\":4033,\"height\":1173,\"caption\":\"France Angels\"},\"image\":{\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59\",\"name\":\"France Angels\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g\",\"caption\":\"France Angels\"},\"url\":\"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Genexpath est membre du programme Paris Saclay Cancer Cluster - France Angels","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/","og_locale":"en_US","og_type":"article","og_title":"Genexpath est membre du programme Paris Saclay Cancer Cluster - France Angels","og_description":"Genexpath, soutenue par Angels Sant\u00e9, fait d\u00e9sormais partie aupr\u00e8s de 6 autres start-ups du programme Paris Saclay Cancer Cluster.","og_url":"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/","og_site_name":"France Angels","article_publisher":"https:\/\/facebook.com\/france.angels\/","article_published_time":"2024-10-21T08:32:33+00:00","author":"France Angels","twitter_card":"summary_large_image","twitter_creator":"@franceangels","twitter_site":"@franceangels","twitter_misc":{"Written by":"France Angels","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/#article","isPartOf":{"@id":"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/"},"author":{"name":"France Angels","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59"},"headline":"Genexpath est membre du programme Paris Saclay Cancer Cluster","datePublished":"2024-10-21T08:32:33+00:00","dateModified":"2024-10-21T08:32:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/"},"wordCount":325,"commentCount":0,"publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"keywords":["Angels Sant\u00e9","France 2030","France 2030 NextGenerationEU","Genexpath","Paris Saclay Cancer Cluster","Programme"],"articleSection":["L'\u00e9cosyst\u00e8me","La start-up du mois"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/","url":"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/","name":"Genexpath est membre du programme Paris Saclay Cancer Cluster - France Angels","isPartOf":{"@id":"https:\/\/www.franceangels.org\/#website"},"datePublished":"2024-10-21T08:32:33+00:00","dateModified":"2024-10-21T08:32:33+00:00","breadcrumb":{"@id":"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.franceangels.org\/article\/genexpath-est-membre-du-programme-paris-saclay-cancer-cluster\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.franceangels.org\/en\/"},{"@type":"ListItem","position":2,"name":"Genexpath est membre du programme Paris Saclay Cancer Cluster"}]},{"@type":"WebSite","@id":"https:\/\/www.franceangels.org\/#website","url":"https:\/\/www.franceangels.org\/","name":"France Angels","description":"F\u00e9d\u00e9ration Nationale des Business Angels","publisher":{"@id":"https:\/\/www.franceangels.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.franceangels.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.franceangels.org\/#organization","name":"France Angels","url":"https:\/\/www.franceangels.org\/","sameAs":["https:\/\/linkedin.com\/company\/france-angels","https:\/\/www.youtube.com\/channel\/UC5_t1C5xO9AloWjY4o5ob_Q","https:\/\/facebook.com\/france.angels\/","https:\/\/twitter.com\/franceangels"],"logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","contentUrl":"https:\/\/www.franceangels.org\/wp-content\/uploads\/2022\/04\/Logo-France-Angels.png","width":4033,"height":1173,"caption":"France Angels"},"image":{"@id":"https:\/\/www.franceangels.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/23bc1670ad5f0f132d0c3610b1ad2b59","name":"France Angels","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.franceangels.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7686aa9e66054004e747510168483db8?s=96&d=mm&r=g","caption":"France Angels"},"url":"https:\/\/www.franceangels.org\/en\/article\/author\/france-angels\/"}]}},"_links":{"self":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/19211"}],"collection":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/users\/114"}],"replies":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/comments?post=19211"}],"version-history":[{"count":0,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/posts\/19211\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/media?parent=19211"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/categories?post=19211"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.franceangels.org\/en\/wp-json\/wp\/v2\/tags?post=19211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}